PremiumPre-EarningsIs CRIS a Buy, Before Earnings? Curis files to sell 2.4M shares of common stock for holders Curis announces additional data from TakeAim leukemia study PremiumPre-EarningsCRIS Earnings this Week: How Will it Perform? Curis price target lowered to $20 from $26 at H.C. Wainwright Curis sells 2.398M shares at $4.92 in registered direct offering PremiumThe FlyCuris announces data from ongoing TakeAim Leukemia study Curis Inc. Insiders Hold Steady: No New Trades Signal Confidence or Complacency? Curis price target raised to $27 from $15 at JonesResearch 
